PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow
Post-market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm Soft Tissue System (Implants and Instrumentation) in the Elbow - A Multicenter Retrospective Consecutive Study
Sponsor: Zimmer Biomet
Listed as NCT05519228, this observational or N/A phase trial focuses on Biceps Tendon Disorder and Epicondylitis of the Elbow and remains completed. Sponsored by Zimmer Biomet, it has been updated 9 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Dec 2024 — Feb 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Dec 2023 — Jan 2024 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Mar 2023 — Dec 2023 [monthly]
Enrolling By Invitation
-
Nov 2022 — Mar 2023 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .